ZA877560B - Thrombolytic therapy - Google Patents

Thrombolytic therapy

Info

Publication number
ZA877560B
ZA877560B ZA877560A ZA877560A ZA877560B ZA 877560 B ZA877560 B ZA 877560B ZA 877560 A ZA877560 A ZA 877560A ZA 877560 A ZA877560 A ZA 877560A ZA 877560 B ZA877560 B ZA 877560B
Authority
ZA
South Africa
Prior art keywords
thrombolytic therapy
thrombolytic
therapy
Prior art date
Application number
ZA877560A
Other languages
English (en)
Inventor
Tsuneo Fujita
Fujita Tsuneo
Ronald John Shebuski
John Shebuski Ronald
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA877560B publication Critical patent/ZA877560B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA877560A 1986-10-09 1987-10-08 Thrombolytic therapy ZA877560B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91712286A 1986-10-09 1986-10-09

Publications (1)

Publication Number Publication Date
ZA877560B true ZA877560B (en) 1988-08-31

Family

ID=25438370

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA877560A ZA877560B (en) 1986-10-09 1987-10-08 Thrombolytic therapy

Country Status (13)

Country Link
EP (1) EP0265129A1 (xx)
JP (1) JPS6396134A (xx)
KR (1) KR880004820A (xx)
AU (2) AU7950187A (xx)
DK (2) DK530087A (xx)
FI (1) FI874440A (xx)
HU (1) HUT44942A (xx)
IE (1) IE872688L (xx)
MY (1) MY101942A (xx)
NO (1) NO874213L (xx)
NZ (2) NZ221977A (xx)
PT (1) PT85898B (xx)
ZA (1) ZA877560B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8805077D0 (en) * 1988-03-03 1988-03-30 Glaxo Group Ltd Pharmaceutical combinations
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
WO1991001142A1 (en) * 1989-07-20 1991-02-07 Biogen, Inc. Combinations and methods for treating or preventing thrombotic diseases
US5643872A (en) * 1989-10-23 1997-07-01 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
DE4010536A1 (de) * 1990-04-02 1991-10-10 Boehringer Mannheim Gmbh Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen

Also Published As

Publication number Publication date
MY101942A (en) 1992-02-15
AU7950187A (en) 1988-04-14
DK528489A (da) 1989-10-24
NZ221977A (en) 1991-03-26
DK528489D0 (da) 1989-10-24
JPS6396134A (ja) 1988-04-27
AU4106889A (en) 1989-12-14
DK530087A (da) 1988-04-10
NZ230742A (en) 1991-03-26
FI874440A (fi) 1988-04-10
PT85898B (pt) 1990-08-31
FI874440A0 (fi) 1987-10-08
HUT44942A (en) 1988-05-30
NO874213L (no) 1988-04-11
NO874213D0 (no) 1987-10-08
DK530087D0 (da) 1987-10-09
IE872688L (en) 1988-04-09
PT85898A (en) 1987-11-01
KR880004820A (ko) 1988-06-27
EP0265129A1 (en) 1988-04-27

Similar Documents

Publication Publication Date Title
GB2188234B (en) Therapeutic agents
GB8607761D0 (en) Magnetic therapy
GB8513369D0 (en) Treatment
ZA86433B (en) Novel treatment
GB8515845D0 (en) Treatment
ZA877560B (en) Thrombolytic therapy
GB8531608D0 (en) Treatment
GB8709764D0 (en) Combination therapy
ZA877885B (en) Therapeutic agents
GR862004B (en) Novel treatment
GB8520651D0 (en) Treatment
GB8525202D0 (en) Treatment
GB8519306D0 (en) Treatment
GB8509039D0 (en) Treatment
GB8531614D0 (en) Treatment
GB8629663D0 (en) Therapeutic agents
CA55805S (en) Solarium
CA56445S (en) Solarium
GB8501707D0 (en) Therapy
GB8427619D0 (en) Therapy
GB8522582D0 (en) Treatment
GB8516269D0 (en) Treatment
GB8528807D0 (en) Treatment
GB8524349D0 (en) Treatment
GB8523963D0 (en) Treatment